Reuters: Supreme Court denies Teva stay in Copaxone patent fight

WASHINGTON (Reuters) - U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd to stay a lower-court ruling in a patent case that favored the developers of generic versions of Teva's top-selling multiple sclerosis drug. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/SIy96ooopRc/story01.htm

Read More